A procedure for the purification of neutral maltase from human polymorphonuclear leukocytes is described, involving solubilization with Triton X-100, proteolytic attack and three chromatographic steps: DEAE ion exchange, AcA 22 gel filtration and a second DEAE chromatography. The enzyme was obtained with a final specific activity of 30 units/mg of protein, comparable with that of other neutral maltases previously purified. The Mr of the enzyme was 550000 as determined by gel filtration. SDS/polyacrylamide-gel electrophoresis, under non-denaturing conditions, led to a major band of 500000 and a minor one of 260000, both active, suggesting a polymeric or aggregated form of the protein. The catalytic properties of the human granulocytic neutral maltase were investigated. The pH optimum was around 6. The enzyme exhibited a broad range of substrate specificity, hydrolysing di-and oligosaccharides with a(l -+ 2), a(l -+ 3) and z(1 -. 4) glucosidic linkages. The highest activities were observed for a(l -.4) glucose oligomers of three to five residues. It was also found to hydrolyse polysaccharides such as starch and glycogen. The results of the inhibition studies are interpreted in terms of the existence of a large site including several subsites. The enzyme properties are broadly similar to those observed for other purified neutral a-glucosidases, in particular that of human kidney origin.
INTRODUCTION
Neutral maltases (a.-D-glucoside glucohydrolases, EC 3.2.1.20) are a-glucosidases which split glucose residues from the non-reducing ends of various a-glycans ranging from simple disaccharides to high-M, polysaccharides like starch. These enzymes have been purified and characterized from intestinal and renal brush borders from several animal species and man (for review : Semenza, 1986 : Semenza, ,1987 . Human leukocytic neutral maltase distribution and its evolution in a number of leukaemic disorders have been investigated. Neutral maltase expression seemed to be the first enzymic marker of Blymphocyte terminal differentiation (Giudicelli et al., 1983; Philip et al. 1983a) . Furthermore, the granulocytic neutral maltase activity was.found in mature granulocytes from normal subjects while it was respectively decreased or undetectable in patients suffering from chronic or acute myeloid leukaemias (Philip et al., 1982) . These data suggested a correlation between the expression ofenzymic activity and the maturation stage reached by the granulocytic lineage cells. Neutral maltase, thus, may be a useful marker for further studies of lymphoid and myeloid cell differentiation.
The aim of the present study was to develop a purification procedure for human granulocytic neutral maltase and to investigate some of the properties of the isolated enzyme.
EXPERIMENTAL Chemicals
Maltose, trehalose, sucrose, soluble starch (Giudicelli et al., 1985) , 2-mercaptoethanol, Triton X-100 and SDS were obtained from Merck. Maltotriose, maltotetraose, maltopentaose, maltohexaose, maltoheptaose, nigerose, cellobiose, turanose, phlorizin and NEM were supplied by Sigma Chemical Co. Tris and glycogen were purchased from Boehringer Mannheim. DEAE-Sepharose 'fast flow' and the Mr marker proteins were obtained from Pharmacia. Ultrogel AcA 22 was a product of Industries Biologiques Frangaises (Villeneuve La Garenne, France).
Isomaltose was purchased from BDH, kojibiose from Koch-Light-Laboratories and papain from United States Biochemical Corporation (Cleveland, OH, U.S.A.).
Enzyme purification
Source of human polymorphonuclear leukocytes. A granulocyte-rich blood fraction was obtained by leukopheresis (Goldman et al., 1978) from patients affected by chronic myeloid leukaemia in a stable phase of the disease. Contaminating erythrocytes and platelets were removed (Onali et al., 1985) . The leukocyte preparations were over 90 % of neutrophilic lineage (mainly polymorphonuclear cells together with a few metamyelocytes and myelocytes).
All purification steps were performed at 4°C unless mentioned otherwise.
Step 1. Homogenization and solubilization. The cells were pelleted (400 g, 10 min) and washed twice with 10 vol. of 150 mM-NaCl solution. The cells were then homogenized by means of an Ultra-Turrax homogenizer in 5 vol. of 50 mM-sodium phosphate buffer, pH 6.0, containing 1 mM-2-mercaptoethanol and 1 mM-PMSF for 30 s periods. This homogenate was used as a reference Step 2. Papain proteolysis. The supernatant was treated with 2 % papain (w/w of protein) and incubated for 60 min at 37°C (Louvard et al., 1975) . Proteolysis was stopped by addition of NEM to a 6 mm final concentration, the preparation was centrifuged (105 000 g, 60 min) and the supernatant was collected.
Step 3. Ion-exchange chromatography on DEAESepharose 'fast flow'. The supernatant was applied to a DEAE-Sepharose 'fast flow' column (4 cm x 11 cm) previously equilibrated with 50 mM-NaH2PO4, pH 6.0, containing 1 mM-2-mercaptoethanol, I mm-NEM and 1 mM-PMSF (buffer A). The column was washed with at least 5 column vol. of buffer A and eluted (flow rate 120 ml/h) with a 0-250 mM-NaCl linear gradient in buffer A (see Fig. 1 ). The fractions containing the neutral ac-glucosidase activity were pooled, concentrated and dialysed overnight against a 50 mM-Tris/HCl buffer, pH 7.0, containing 1 mM-2-mercaptoethanol and 0.1 % SDS (buffer B) with a Microprodicon dialysis apparatus (Bioblock Scientific, Illkirch, France) using a PM 30 membrane.
Step 4. Gel filtration on Ultrogel AcA 22. The concentrated solution was applied to an Ultrogel AcA 22 column (1.6 cm x 90 cm) equilibrated with buffer B. The column was eluted (flow rate 10 ml/h) with the same buffer (see Fig. 2 ). The fractions containing neutral aglucosidase activity were pooled and dialysed overnight against 50 mM-NaH2PO4, pH 6.0, containing 1 mM-2-mercaptoethanol (buffer C).
Step 5. Chromatography on DEAE-Sepharose 'fast flow'. The resulting solution was applied to another DEAE-Sepharose 'fast flow' column (2.5 cm x 7 cm) previously equilibrated with buffer C. After elution of non-adsorbed proteins by at least 5 column vol. of the same buffer, the neutral a-glucosidase was eluted with a 25-200 mM-NaCI linear gradient in buffer C (flow rate 25 ml/h). The active fractions were pooled, concentrated and dialysed against buffer C.
Assay for neutral a-D-glucosidase
Neutral cc-D-glucosidase activity was measured in the presence of 5 mM-maltose in a 100 mM-sodium citrate buffer, pH 6.25 (De Burlet & Sudaka, 1976) . After incubation at 37 'C, glucose was assayed by the glucose oxidase/peroxidase procedure of Dahlqvist (1968) . One unit of neutral LZ-D-glucosidase activity was defined as the amount of enzyme required to hydrolyse 1 ,umol of maltose/min under the assay conditions. Hydrolysis of other oligo-and polysaccharides was measured by the same glucose oxidase method. Protein determination Protein concentrations were determined according to. The column was equilibrated and, after sample loading, washed with buffer A (see the Experimental section). The bound enzyme was eluted with a linear gradient of 0-250 mM-NaCl. Protein was measured by absorbance at 280 nm and maltase activity was monitored at 420 nm. The flow rate was 120 ml/h and fraction volumes were 3.5 ml.
1989
(1978) was used. In both cases, bovine serum albumin was used as a standard. Enzyme purity and identity Electrophoresis experiments were carried out in an LKB 2001 vertical gel slab unit. Polyacrylamide gradient gels (4-12 00) with the modified multiphasic buffer system of Laemmli (1970) were used (Starita-Geribaldi et al., 1987) . Electrophoresis was run at 1O mA at 6°C for 16 h. The gels were stained for protein with Coomassie Brilliant Blue or with silver by the method of Henkeshoven & Dernick (1985) .
Maltase activity was visualized after transfer on to nitrocellulose, using maltose as substrate (Danielsen et al., 1977) . Relative molecular mass This was determined by two different techniques. A 3.50 polyacrylamide gel was run (Starita-Geribaldi et al., 1988) with the following molecular mass indicators: thyroglobulin dimer (Mr 669000), ferritin dimer (440000), thyroglobulin monomer (330000) and ferritin monomer (220 000). Alternatively, a gel filtration determination was performed on an Ultrogel AcA 22 column (1.6 cm x 90 cm) equilibrated and eluted with 50 mM-sodium phosphate buffer, pH 7.4, containing 100 mM-NaCl. The reference proteins were thyroglobulin (Mr 669000), ferritin (220000), catalase (185000) and aldolase (158000).
protein was eluted as a single symmetric peak. SDS/ polyacrylamide-gel electrophoresis, however, showed two bands of Mr 500000 and 260000. Kinetic properties pH optimum. Maltase activity was investigated between pH 2.0 and 12.0 (Teorell & Stenhagen, 1938) 
RESULTS

Enzyme purification
The results of a typical purification of neutral a-Dglucosidase from human neutrophils are summarized in Table 1 . The procedure resulted in a 1200-fold purification with a 28 0 overall yield. The final specific enzyme activity was found to be around 30 units/mg of protein.
Purity and identity of the enzyme preparation
The purity of the final product was checked by polyacrylamide-gel electrophoresis. Two bands were stained by both silver and Coomassie Blue (Fig. 3) . These bands coincided with the two active bands visualized histochemically after transfer on to nitrocellulose. Relative molecular mass
The Mr of the enzyme was estimated at 550000 by gel filtration on Ultrogel AcA 22 from which the purified maximal activity towards maltose was observed around pH 6.0.
Substrate specificity. The enzyme specificity for the hydrolysis of a number of substrates differing in their conformation, linkage type or glucidic chain length was investigated (see Table 2 The specificity for the hydrolysis of some oligo-and polysaccharides was also investigated. The maltooligosaccharides were better substrates than maltose and the catalytic efficiency optimum occurred for a length of three to five glucose residues. Two polysaccharides were tested (starch and glycogen); only weak glucosidase activity towards starch was noted. Substrate inhibition was observed with malto-oligosaccharides at concentrations exceeding 0.5 mm (Fig. 4) and with starch at concentrations over 2.5 g/ml (not shown). In contrast, no substrate inhibition was observed with maltose (up to 10 mM) or with the other disaccharides tested.
Inhibition studies. Several compounds were tried as inhibitors for maltose, maltotriose and starch hydrolysis (Table 3) . Turanose competitively inhibited the hydrolysis of maltose, maltotriose and starch with the same inhibition constants. Trehalose inhibited starch and maltotriose hydrolysis competitively but did not affect maltose hydrolysis. Inhibition by Tris was found to be of a mixed type. Phlorizin inhibited the hydrolysis of the three substrates, non-competitively and with the same affinity.
DISCUSSION
This paper reports the first purification procedure of neutral maltase from human polymorphonuclear leukocytes. As the amount of available starting material is limited, a high overall yield is of particular importance. The 280 yield obtained is comparable to those described for purifications from other tissues (Schlegel-Haueter et al., 1972; De Burlet & Sudaka, 1976; Giudicelli et al., 1980; Reiss & Sacktor, 1981) . This, together with the excellent purification factor (1200), the high purity of the product obtained, and the specific activity comparable to that reported for the human intestinal (Kelly & Alpers, 1973) and renal (De Burlet & Sudaka, 1976) maltases, demonstrates the efficiency of the method.
The granulocytic neutral maltase has first to be released by a cellular lysis (Philip et al., 1982) , which suggests that the enzyme is located intracellularly, in contrast to the intestinal and renal neutral maltases which are described as membrane ectoenzymes (Kenny & Maroux, 1982; 1989 Semenza, 1986 . The release of maltase is achieved by treatment with Triton X-100 followed by papain digestion. The amount of maltase activity slightly increases at this stage, suggesting a removal of a structural hindrance to the enzyme by this procedure. A similar observation during the isolation of rat kidney neutral maltase has been reported (Reiss & Sacktor, 1981) . The purification is completed using conventional chromatographic steps. The use of a 'fast flow' DEAE-Sepharose significantly reduces the duration of these steps and hence results in higher yields. The use of the Microprodicon, which dialyses and concentrates the chromatographic fractions in a single step, was found to be particularly convenient.
The enzyme purity was checked by polyacrylamide-gel electrophoresis under non-denaturing conditions. In addition to a major band of Mr 500000, which corresponds to the neutral maltase peak of 550000 observed on gel filtration, this procedure reveals a minor fraction of an Mr-260 000 active protein. This minor band may be attributed to a partial dissociation of a polymeric or aggregated protein under the electrophoresis conditions (Flanagan & Forstner, 1978; Sorensen et al., 1982; Lee & Forstner, 1984; Noren et al., 1986) . Further studies on the quaternary structure of human granulocytic neutral maltase are in progress.
The specificity of the enzyme with respect to a number of di-and polysaccharides was investigated (see Table 2 ). In addition to maltose [a(l -+ Burlet & Sudaka, 1977; Giudicelli et al., 1980; Reiss & Sacktor, 1981) .
The malto-oligosaccharides were the best substrates investigated; the catalytic efficiency optimum occurs for oligosaccharides of three to five glucose residues. This conflicts with a recent report in which a human granulocytic microsomal fraction was found not to hydrolyse matlo-oligosaccharides (Stio et al., 1987) . This may be explained by the high substrate concentrations used, which we have found to be inhibitory. Indeed substrate inhibition by maltosaccharides seems to be a general property of acid and neutral maltases (Palmer, 1971 a; Sivakami & Radhakrishnan, 1976; De Burlet & Sudaka, 1977; Giudicelli et al., 1980) . It is noteworthy that all the substrates (with the exception of trehalose) undergo hydrolysis with similar maximal velocities. This suggests that a common catalytic process acts on glucosidic bonds between the aldehydic function (C-I) of a glucose residue and one of the secondary alcohol functions of another glucose.
Finally, the effects of a number of a-glucosidase inhibitors on the purified enzyme were studied (Table 3) (Palmer, 1971 b; Sivakami & Radhakrishnan, 1976; De Burlet & Sudaka, 1977; Giudicelli et al., 1980) . This implies the existence of several binding subsites; the binding of maltotriose and starch will probably require a large site (adjusted to three to five glucose residues) including several zones involved in the binding of maltose and trehalose.
All the physicochemical data considered together suggest that human granulocytic neutral maltase has very similar properties to other neutral a-glucosidases, in particular that of human renal origin.
We consider that the purification procedure reported here for neutral maltase, which is the first to be described from human granulocytes, is efficient and convenient to obtain a pure antigenic fraction as a starting material for a specific antibody preparation. We are now assaying the immunological properties of the protein in order to determine whether these antibodies could be used as a marker for human lymphoid and myeloid differentiation studies (Philip et al., 1982 (Philip et al., , 1983a and for the follow-up of chronic myeloid leukaemias (Philip et al., 1983b) .
